Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer

Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer

A total of 27 patients with advanced previously untreated non-small-cell lung cancer were treated with paclitaxel and ifosfamide. The starting dose of paclitaxel was 175 mg/m2 given for 3 h by intravenous infusion on day 1. Ifosfamide 4 g/m2 was given for 4 h by intravenous infusion on day 2. Dosage...

Saved in:

書目詳細資料
主要作者:	Thongprasert S.
格式:	Clinical Trial
語言:	English
出版:	2014
在線閱讀:	http://www.ncbi.nlm.nih.gov/pubmed/3502482 http://cmuir.cmu.ac.th/handle/6653943832/3409
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University
語言:	English

相似書籍

Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer
由: Thongprasert S.
出版: (2014)

Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC)
由: Thongprasert S., et al.
出版: (2014)

Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer
由: Goh, B.C., et al.
出版: (2014)

Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
由: Charoentum C., et al.
出版: (2014)

Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
由: Chaiyut Charoentum, et al.
出版: (2018)

Paclitaxel and carboplatin plus megestrol acetate in the treatment of advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer
由: Ratanatharathorn V., et al.
出版: (2014)

Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer
由: Vorachai Ratanatharathorn, et al.
出版: (2018)

Phase II study of concurrent chemoradiotherapy for inoperable (Bulky) stage III (A/B) Non-Small Cell Lung Cancer (NSCLC) : A preliminary report
由: Vorachai Ratanatharathorn, et al.
出版: (2018)

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
由: Sumitra Thongprasert, et al.
出版: (2018)

A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer
由: Sumitra Thongprasert, et al.
出版: (2018)

Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
由: Charoentum C., et al.
出版: (2014)

Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
由: Chaiyut Charoentum, et al.
出版: (2018)

Effects of paclitaxel and carboplatin on quality of life and survival in patients with advanced non-small-cell lung cancer
由: Vorachai Ratanatharathorn, et al.
出版: (2018)

Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
由: Chitapanarux I., et al.
出版: (2014)

Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
由: I. Chitapanarux, et al.
出版: (2018)

Paclitaxel and Carboplatin in Combination in the Treatment of Advanced Non-small-cell Lung Cancer (NSCLC) : A Preliminary Study
由: Vorachai Ratanatharathorn, et al.
出版: (2018)

Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
由: Thongprasert S., et al.
出版: (2014)

Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
由: S. Thongprasert, et al.
出版: (2018)

Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers
由: Feng, S.-S., et al.
出版: (2014)

Docetaxel as second-line chemotherapy for advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Nanospheres of biodegradable polymers: A system for clinical administration of an anticancer drug paclitaxel (Taxol®)
由: Feng, S.S., et al.
出版: (2014)

Polymeric nanospheres fabricated with natural emulsifiers for clinical administration of an anticancer drug paclitaxel (Taxol®)
由: Feng, S.-S., et al.
出版: (2014)

Efficacy and tolerability of tropisetron in the prevention of cisplatin-induced nausea and vomiting in advanced non-small cell lung cancer
由: Thongprasert S.
出版: (2014)

Molecular interactions between lipid and paclitaxel (Taxol®) within cell membrane simulated by the lipid monolayer at the air-water interface
由: Gong, K., et al.
出版: (2014)

Molecular interactions between lipid and paclitaxel (Taxol®) within cell membrane simulated by the lipid monolayer at the air-water interface
由: Gong, K., et al.
出版: (2014)

Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients
由: Sorraritchingchai S., et al.
出版: (2014)

Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital
由: Thongprasert S.
出版: (2014)

Vitamin E TPGS used in the solvent extraction/evaporation technique for fabrication of polymeric nanospheres of an antineoplastic drug paclitaxel (taxol®) for cancer chemotherapy
由: Mu, L., et al.
出版: (2014)

Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with reviously treated advanced non-small-cell lung cancer
由: Tony S. Mok, et al.
出版: (2018)

Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with reviously treated advanced non-small-cell lung cancer
由: Tony S. Mok, et al.
出版: (2018)

Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with reviously treated advanced non-small-cell lung cancer
由: Mok T.S., et al.
出版: (2014)

Erlotinib in previously treated non-small-cell lung cancer
由: Frances A. Shepherd, et al.
出版: (2018)

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand
由: Thongprasert S., et al.
出版: (2017)

Metabolic engineering for the optimal production of Taxol (Paclitaxel) - an efficient anticancer drug (focusing on upstream pathways for isoprenoid accumulation).
由: Ng, James Shizhao.
出版: (2013)